CTOs on the Move

Cybertech Medical

www.cybertechmedical.com

 
Cybertech Medical is a La Verne, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

GuideWell

GuideWell Mutual Holding Corporation is a not-for-profit mutual holding company that is the parent to a family of forward-thinking companies focused on transforming health care.

United Claim Solutions

United Claim Solutions was started by Joshua Carder in 2004. Joshua had been in the cost containment industry for a number of years, and through that experience realized there were efficiencies and solutions that could be introduced to lower medical and administrative costs for self-insured employers, labor organizations, payers and insurers. The mission of United Claim Solutions is to be a leader and innovator of products and services for healthcare payers. We will provide superior Service, Savings and Solutions to our customers while never compromising the quality of care delivered to covered individuals.

JTECH Medical

JTECH Medical is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MusclePharm

MusclePharm is an award winning and worldwide leading sports nutrition brand. Our expansive line of clinically proven safe and effective supplements reaches all elements of the active, push-the-edge lifestyle—from muscle building, athletic performance, weight loss and general fitness.

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.